2C-O-4
![]() | |
![]() | |
Clinical data | |
---|---|
Other names | 4-Isopropoxy-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-isopropoxyphenethylamine |
Routes of administration | Oral[1] |
ATC code |
|
Pharmacokinetic data | |
Duration of action | A few hours[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H21NO3 |
Molar mass | 239.315 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
2C-O-4, also known as 4-isopropoxy-2,5-dimethoxyphenethylamine, is a phenethylamine of the 2C family.[1] It is also a positional isomer of isoproscaline and was probably first synthesized by Alexander Shulgin.[1] It produces hallucinogenic or psychedelic effects.[1] Because of the low potency of 2C-O-4, and the inactivity of 2C-O, Shulgin felt that the 2C-O series would not be an exciting area for research, and did not pursue any further analogues.[1]
Use and effects
[edit]Little is known about the psychopharmacological effects of 2C-O-4.[1] Based on the one report available in his book PiHKAL, Shulgin lists the dose of 2C-O-4 as being >60 mg.[1] At 60 mg, threshold psychoactive effects occurred.[1] These included awareness of something in the front part of the head, yawning, physiological changes, and a general exhilaration and excitement.[1] The effects lasted a few hours and were rated as a +1 on the Shulgin Rating Scale.[1] The drug was regarded as remaining to be fully explored.[1]
Toxicity
[edit]The toxicity of 2C-O-4 is not known.
Pharmacology
[edit]The pharmacology of 2C-O-4 has been studied.[2]
Chemistry
[edit]2C-O-4 is in a class of compounds commonly known as phenethylamines, and the systematic chemical name is 2-(4-isopropoxy-2,5-dimethoxyphenyl)ethanamine.
Society and culture
[edit]Legal status
[edit]Canada
[edit]As of October 31, 2016, 2C-O-4 is a controlled substance (Schedule III) in Canada.[3]
United States
[edit]2C-O-4 is unscheduled and unregulated in the United States; however, because of its close similarity in structure and effects to mescaline and 2C-T-7, possession and sale of 2C-O-4 may be subject to prosecution under the Federal Analog Act.
See also
[edit]References
[edit]- ^ a b c d e f g h i j k l Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. 2C-O-4 Entry in PiHKAL
- ^ Kolaczynska KE, Luethi D, Trachsel D, Hoener MC, Liechti ME (2019). "Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines". Front Pharmacol. 10: 1423. doi:10.3389/fphar.2019.01423. PMC 6893898. PMID 31849671.
- ^ "Canada Gazette – Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". 4 May 2016.
Phenethylamines |
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amphetamines |
| ||||||||||||||||
Phentermines |
| ||||||||||||||||
Cathinones |
| ||||||||||||||||
Phenylisobutylamines (and further-extended) | |||||||||||||||||
Catecholamines (and close relatives) |
| ||||||||||||||||
Cyclized phenethylamines |
| ||||||||||||||||
Related compounds |
| ||||||||||||||||